Trial Profile
A Phase 1, Single-centre, Double-blind, Placebocontrolled Crossover Study to Assess the pharmacoMRI Effects of AUT00206 in Healthy Male Participants
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 29 Nov 2017
Price :
$35
*
At a glance
- Drugs AUT 00206 (Primary)
- Indications Schizophrenia
- Focus Pharmacodynamics
- Sponsors Autifony Therapeutics
- 22 Nov 2017 Status changed from recruiting to completed.
- 22 Jun 2016 New trial record